TY - JOUR
T1 - Correction to :
T2 - Foreword (Clinical Drug Investigation, (2022), 42, S1, (1-2), 10.1007/s40261-022-01148-4)
AU - Mínguez Rosique, Beatriz
AU - Lledó-Navarro, José Lluis
PY - 2022
Y1 - 2022
N2 - The affiliations of José Luis Lledó-Navarro in the original version of this article were not correct. The correct affiliations are given below. 5. Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Madrid, Spain 6. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain 7. Centro de Investigación Biomédica en Red (CIBERehd), Madrid, Spain 8. Universidad de Alcalá, Madrid, Spain.
AB - The affiliations of José Luis Lledó-Navarro in the original version of this article were not correct. The correct affiliations are given below. 5. Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Madrid, Spain 6. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain 7. Centro de Investigación Biomédica en Red (CIBERehd), Madrid, Spain 8. Universidad de Alcalá, Madrid, Spain.
U2 - 10.1007/s40261-022-01174-2
DO - 10.1007/s40261-022-01174-2
M3 - Article
C2 - 35788977
SN - 1173-2563
VL - 42
JO - Clinical Drug Investigation
JF - Clinical Drug Investigation
IS - 8
ER -